1. Fakheri H, Janbabai G, Bari Z, Eshqi F. The epidemiologic and clinical-pathologic characteristics of colorectal cancers from 1999 to 2007 in Sari, Iran. Journal of Mazandaran University of Medical Sciences 2008;18:58-66. [In Persian]

2. Lam K, Pan K, Linnekamp JF, Medema JP, Kandimalla R. DNA methylation based biomarkers in colorectal cancer: a systematic review. Biochim Biophys Acta 2016;1866:106-20. [DOI:10.1016/j.bbcan.2016.07.001]

3. Rahimi Pordanjani S, Baeradeh N, Lotfi MH, Pourmohammadi B. Epidemiology of colorectal cancer: incidence, mortality, survival rates and risk factors. Razi J Med Sci 2016;23:41-50.

4. Arvelo F, Sojo F, Cotte C. Biology of colorectal cancer. Ecancermedicalscience 2015;9:520. [DOI:10.3332/ecancer.2015.520]

5. Benson AB, Venook AP, Cederquist L, Chan E, Chen Y-J, Cooper HS, et al. Colon cancer, version 1.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2017;15:370-98. [DOI:10.6004/jnccn.2017.0036]

6. Grady WM, Markowitz SD. The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening. Dig Dis Sci 2015;60:762-72. [DOI:10.1007/s10620-014-3444-4]

7. Nedaeinia R, Sharifi M, Avan A, Kazemi M, Nabinejad A, Ferns GA, et al. Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4. Tumor Biol 2017;39:1010428317692261. [DOI:10.1177/1010428317692261]

8. Saebnia N, Sadeghizadeh M, Movahedi Motlagh F, Esmatabadi D, Javad M. A Review of Genes, Markers, and Methods in Predicting Colon Cancer Recurrence. J Police Med 2017;5:389-402.

9. Siravegna G, Bardelli A. Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients. Mol Oncol 2016;10:475-80. [DOI:10.1016/j.molonc.2015.12.005]

10. Henry NL, Hayes DF. Cancer biomarkers. Mol Oncol 2012;6:140-6. [DOI:10.1016/j.molonc.2012.01.010]

11. Yun Y-R, Won JE, Jeon E, Lee S, Kang W, Jo H, et al. Fibroblast growth factors: biology, function, and application for tissue regeneration. J Tissue Eng 2010;1:218142. [DOI:10.4061/2010/218142]

12. Sato T, Oshima T, Yoshihara K, Yamamoto N, Yamada R, Nagano Y, et al. Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer. Oncol Reports 2009;21:211-6.

13. Jang J-H. Reciprocal relationship in gene expression between FGFR1 and FGFR3: implication for tumorigenesis. Oncogene 2005;24:945. [DOI:10.1038/sj.onc.1208254]

14. Hossain WA, Morest D. Fibroblast growth factors (FGF‐1, FGF‐2) promote migration and neurite growth of mouse cochlear ganglion cells in vitro: immunohistochemistry and antibody perturbation. J. Neurosci Res 2000;62:40-55. https://doi.org/10.1002/1097-4547(20001001)62:1<40::AID-JNR5>3.0.CO;2-L [DOI:10.1002/1097-4547(20001001)62:13.0.CO;2-L]

15. https://doi.org/10.1002/1097-4547(20001001)62:1<40::AID-JNR5>3.0.CO;2-L https://doi.org/10.1002/1097-4547(20001001)62:1<40::AID-JNR5>3.0.CO;2-L [DOI:10.1002/1097-4547(20001001)62:13.0.CO;2-L]

16. Kottakis F, Polytarchou C, Foltopoulou P, Sanidas I, Kampranis SC, Tsichlis PN. FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/KDM2B-miR-101-EZH2 pathway. Mol Cell 2011;43:285-98. [DOI:10.1016/j.molcel.2011.06.020]

17. Hennessey JA, Wei EQ, Pitt GS. Fibroblast growth factor homologous factors modulate cardiac calcium channels. Circ Res 2013; 113:301215. [DOI:10.1161/CIRCRESAHA.113.301215]

18. Lee KW, Yim HS, Shin J, Lee C, Lee JH, Jeong JY. FGF11 induced by hypoxia interacts with HIF‐1α and enhances its stability. FEBS letters 2017;591:348-57. [DOI:10.1002/1873-3468.12547]

19. Verdier A-S, Mattei M-G, Lovec H, Hartung H, Goldfarb M, Birnbaum D, et al. Chromosomal mapping of two novel human FGF genes, FGF11andFGF12. Genomics 1997;40:151-4. [DOI:10.1006/geno.1996.4492]

20. Goetz R, Dover K, Laezza F, Shtraizent N, Huang X, Tchetchik D, et al. Crystal structure of a fibroblast growth factor homologous factor (FHF) defines a conserved surface on FHFs for binding and modulation of voltage-gated sodium channels. J Biol Chem 2009;284:17883-96. [DOI:10.1074/jbc.M109.001842]

21. Ye SB, Zhang H, Cai TT, Liu YN, Ni JJ, He J, et al. Exosomal miR‐24‐3p impedes T‐cell function by targeting FGF11 and serves as a potential prognostic biomarker for nasopharyngeal carcinoma. J Pathol 2016;240:329-40. [DOI:10.1002/path.4781]

22. Knowles HJ. Hypoxia-induced fibroblast growth factor 11 stimulates osteoclast-mediated resorption of bone. Calcif Tissue Int 2017;100:382-91. [DOI:10.1007/s00223-016-0228-1]

23. Toiyama Y, Takahashi M, Hur K, Nagasaka T, Tanaka K, Inoue Y, et al. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst 2013;105:849-59. [DOI:10.1093/jnci/djt101]

24. Hu S, Li L, Yeh S, Cui Y, Li X, Chang H-C, et al. Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→ miRNA‐541→ androgen receptor (AR)→ MMP9 signaling. Mol Oncol 2015;9:44-57. [DOI:10.1016/j.molonc.2014.07.013]

25. Nguyen MT, Weinberg DS. Biomarkers in colorectal cancer screening. J Natl Compr Canc Netw 2016;14:1033-40. [DOI:10.6004/jnccn.2016.0109]

26. Fakheri H, Janbabai G, Bari Z, Eshqi F. The epidemiologic and clinical-pathologic characteristics of colorectal cancers from 1999 to 2007 in Sari, Iran. Journal of Mazandaran University of Medical Sciences 2008;18:58-66. [In Persian]

27. Lam K, Pan K, Linnekamp JF, Medema JP, Kandimalla R. DNA methylation based biomarkers in colorectal cancer: a systematic review. Biochim Biophys Acta 2016;1866:106-20. [DOI:10.1016/j.bbcan.2016.07.001]

28. Rahimi Pordanjani S, Baeradeh N, Lotfi MH, Pourmohammadi B. Epidemiology of colorectal cancer: incidence, mortality, survival rates and risk factors. Razi J Med Sci 2016;23:41-50.

29. Arvelo F, Sojo F, Cotte C. Biology of colorectal cancer. Ecancermedicalscience 2015;9:520. [DOI:10.3332/ecancer.2015.520]

30. Benson AB, Venook AP, Cederquist L, Chan E, Chen Y-J, Cooper HS, et al. Colon cancer, version 1.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2017;15:370-98. [DOI:10.6004/jnccn.2017.0036]

31. Grady WM, Markowitz SD. The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening. Dig Dis Sci 2015;60:762-72. [DOI:10.1007/s10620-014-3444-4]

32. Nedaeinia R, Sharifi M, Avan A, Kazemi M, Nabinejad A, Ferns GA, et al. Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4. Tumor Biol 2017;39:1010428317692261. [DOI:10.1177/1010428317692261]

33. Saebnia N, Sadeghizadeh M, Movahedi Motlagh F, Esmatabadi D, Javad M. A Review of Genes, Markers, and Methods in Predicting Colon Cancer Recurrence. J Police Med 2017;5:389-402.

34. Siravegna G, Bardelli A. Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients. Mol Oncol 2016;10:475-80. [DOI:10.1016/j.molonc.2015.12.005]

35. Henry NL, Hayes DF. Cancer biomarkers. Mol Oncol 2012;6:140-6. [DOI:10.1016/j.molonc.2012.01.010]

36. Yun Y-R, Won JE, Jeon E, Lee S, Kang W, Jo H, et al. Fibroblast growth factors: biology, function, and application for tissue regeneration. J Tissue Eng 2010;1:218142. [DOI:10.4061/2010/218142]

37. Sato T, Oshima T, Yoshihara K, Yamamoto N, Yamada R, Nagano Y, et al. Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer. Oncol Reports 2009;21:211-6.

38. Jang J-H. Reciprocal relationship in gene expression between FGFR1 and FGFR3: implication for tumorigenesis. Oncogene 2005;24:945. [DOI:10.1038/sj.onc.1208254]

39. Hossain WA, Morest D. Fibroblast growth factors (FGF‐1, FGF‐2) promote migration and neurite growth of mouse cochlear ganglion cells in vitro: immunohistochemistry and antibody perturbation. J. Neurosci Res 2000;62:40-55. https://doi.org/10.1002/1097-4547(20001001)62:1<40::AID-JNR5>3.0.CO;2-L [DOI:10.1002/1097-4547(20001001)62:13.0.CO;2-L]

40. https://doi.org/10.1002/1097-4547(20001001)62:1<40::AID-JNR5>3.0.CO;2-L https://doi.org/10.1002/1097-4547(20001001)62:1<40::AID-JNR5>3.0.CO;2-L [DOI:10.1002/1097-4547(20001001)62:13.0.CO;2-L]

41. Kottakis F, Polytarchou C, Foltopoulou P, Sanidas I, Kampranis SC, Tsichlis PN. FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/KDM2B-miR-101-EZH2 pathway. Mol Cell 2011;43:285-98. [DOI:10.1016/j.molcel.2011.06.020]

42. Hennessey JA, Wei EQ, Pitt GS. Fibroblast growth factor homologous factors modulate cardiac calcium channels. Circ Res 2013; 113:301215. [DOI:10.1161/CIRCRESAHA.113.301215]

43. Lee KW, Yim HS, Shin J, Lee C, Lee JH, Jeong JY. FGF11 induced by hypoxia interacts with HIF‐1α and enhances its stability. FEBS letters 2017;591:348-57. [DOI:10.1002/1873-3468.12547]

44. Verdier A-S, Mattei M-G, Lovec H, Hartung H, Goldfarb M, Birnbaum D, et al. Chromosomal mapping of two novel human FGF genes, FGF11andFGF12. Genomics 1997;40:151-4. [DOI:10.1006/geno.1996.4492]

45. Goetz R, Dover K, Laezza F, Shtraizent N, Huang X, Tchetchik D, et al. Crystal structure of a fibroblast growth factor homologous factor (FHF) defines a conserved surface on FHFs for binding and modulation of voltage-gated sodium channels. J Biol Chem 2009;284:17883-96. [DOI:10.1074/jbc.M109.001842]

46. Ye SB, Zhang H, Cai TT, Liu YN, Ni JJ, He J, et al. Exosomal miR‐24‐3p impedes T‐cell function by targeting FGF11 and serves as a potential prognostic biomarker for nasopharyngeal carcinoma. J Pathol 2016;240:329-40. [DOI:10.1002/path.4781]

47. Knowles HJ. Hypoxia-induced fibroblast growth factor 11 stimulates osteoclast-mediated resorption of bone. Calcif Tissue Int 2017;100:382-91. [DOI:10.1007/s00223-016-0228-1]

48. Toiyama Y, Takahashi M, Hur K, Nagasaka T, Tanaka K, Inoue Y, et al. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst 2013;105:849-59. [DOI:10.1093/jnci/djt101]

49. Hu S, Li L, Yeh S, Cui Y, Li X, Chang H-C, et al. Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→ miRNA‐541→ androgen receptor (AR)→ MMP9 signaling. Mol Oncol 2015;9:44-57. [DOI:10.1016/j.molonc.2014.07.013]

50. Nguyen MT, Weinberg DS. Biomarkers in colorectal cancer screening. J Natl Compr Canc Netw 2016;14:1033-40. [DOI:10.6004/jnccn.2016.0109]